Lila Sciences
55 Cambridge Parkway, Suite 800E, Cambridge, MA, 02142, United States
Overview
Lila Sciences develops an AI-driven platform that trains models on scientific literature across material sciences, chemistry and life sciences and generates experimental hypotheses. The company pairs those model outputs with laboratory setups to experimentally validate and close the loop between prediction and reproducible results. Reporting says Lila aims for a domain‑crossing, general-purpose science enablement stack rather than narrowly focused tools. Financially, it has completed a reported $200 million seed, emerged from stealth last year, and closed a $350 million Series A in October that lifted its valuation above $1.3 billion. Current reporting describes Lila negotiating an approximately $2 billion financing to scale compute, inference and laboratory capacity and to accelerate partner programs. The firm's growth narrative emphasizes standardizing experiment and feedback loops to make discovery repeatable and scalable.
- Total raised
- $550M
- Funding rounds
- 3
- Latest round
- Series A
- Latest activity
- Oct 2025
Industries
- Artificial Intelligence (AI)
- Foundational AI
- Industrial Automation
- Life Science
- Software
Recent funding
Series A
Oct 2025
$115M
Series A
Sep 2025
$235M
Seed
Mar 2025
$200M